Paid Clinical Trials in Commack, NY
As of July 2026, 324 paid clinical trials are recruiting in Commack, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Commack offers studies at sites including Memorial Sloan Kettering Commack for conditions such as Breast Cancer, Multiple Myeloma, Acute Myeloid Leukemia, Prostate Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Commack
Trials by drug in Commack
Filter results
Newly added in Commack
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Lung Cancer Risk
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
A Study of a New PET Scanner in People With Cancer
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
A Study of CRD3874-SI in People With Leukemia
314 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
An Observational Study of Individuals With Isolated Dystonia
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Malignant Polyp Registry
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
A Dietary Study for People With Clonal Hematopoiesis
A Study of Methylprednisolone in People Having Liver Surgery
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
A Study of Mirdametinib in People With Central Nervous System Tumors
A Study of Ivonescimab in People With Leiomyosarcoma
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Top Research Study Locations in Commack
Researchers run research studies in Commack, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Commack | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Breast Cancer | 65 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Multiple Myeloma, Breast Cancer, Glioma | 39 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Anastomotic Leak | 17 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Acute Myeloid Leukemia, Bladder Cancer, Brain Tumor | 13 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Breast Cancer Stage IV | 12 |
| Memorial Sloan Kettering Commack (Limited Protocol Activities) | Breast Cancer, Metastatic Breast Cancer, Brain Tumor | 11 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Gastric Adenocarcinoma, Gastric Cancer, Caregiver Burden | 10 |
| MSK Commack | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 8 |
| Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) | Cancer, Bladder Cancer, Breast Cancer | 8 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer | 8 |
| Memorial Sloan Kettering Suffolk-Commack (Consent Only) | Bladder Cancer, Head and Neck Cancer, Histiocytic Neoplasms | 8 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) | Acute Myeloid Leukemia, AML, Acute Leukemia | 6 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) | Metastatic Breast Cancer, Bone Sarcoma, Breast Cancer | 6 |
| True North Neurology | Migraine, Acute Migraine, Acute Treatment of Migraine | 6 |
| Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) | Ovarian Cancer, Alveolar Soft Part Sarcoma, Extramammary Paget's Disease | 5 |
| Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities) | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Metastatic Renal Cell Carcinoma | 5 |
| Memorial Sloan Kettering Suffolk - Commack | Brain Metastases, Brain Metastases, Adult, Lung Cancer | 5 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) | HNSCC, Head Cancer, Head Cancer Neck | 5 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Endometrial Cancer, Non-Muscle Invasive Bladder Cancer, Non-Small Cell Lung Cancer | 5 |
| Memorial Sloan Kettering Cancer Center @ Commack | Colorectal Cancer, Colorectal Carcinoma, Hodgkin Lymphoma | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Cancer | 4 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) | Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV | 4 |
| Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) | CNS Metastases, Central Nervous System Metastasis, Metastasis | 4 |
| Memorial Sloan Kettering Commack (All Protocol Activities) | Endometrial Cancer, Endometrial Cancer Stage I, Endometrioid Adenocarcinoma | 4 |
| Memorial Sloan Kettering Commack (Consent Only) | Adolescents and Young Adults With Cancer, Radiation Therapy, Breast Cancer | 4 |
Active & Upcoming Studies in Commack (2026)
Recruiting trials in Commack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (254 active studies)
- A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer · Phase 2 · Memorial Sloan Kettering Cancer Center
- A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia · Phase 2 · Memorial Sloan Kettering Cancer Center
Neurology & pain (9 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Pediatric (2 active studies)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Vaccines (1 active study)
HIV / STI (1 active study)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma · Phase 2 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Commack
- Breast Cancer (27 active studies)
- Multiple Myeloma (13 active studies)
- Acute Myeloid Leukemia (12 active studies)
- Prostate Cancer (12 active studies)
- Endometrial Cancer (10 active studies)
- Non-Small Cell Lung Cancer (9 active studies)
Leading research sponsors in Commack
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Commack?
There are approximately 324 recruiting clinical trials in Commack, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Commack pay participants?
Most recruiting trials in Commack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Commack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Commack?
The most common conditions under active study in Commack include Breast Cancer (27), Multiple Myeloma (13), Acute Myeloid Leukemia (12), Prostate Cancer (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Commack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Commack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Commack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Commack?
Recruiting research sites in Commack include Memorial Sloan Kettering Commack, Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Commack right now?
The largest active categories in Commack are Cancer & tumors (254), Neurology & pain (9), Pediatric (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.